Systemic chemotherapy in the treatment of malignant melanoma.
about
Endoplasmic reticulum stress-mediated pathways to both apoptosis and autophagy: Significance for melanoma treatmentCharacterization of Dynamic Behaviour of MCF7 and MCF10A Cells in Ultrasonic Field Using Modal and Harmonic AnalysesFormulation of dacarbazine-loaded cubosomes-part I: influence of formulation variables.Complete regression and systemic protective immune responses obtained in B16 melanomas after treatment with LTX-315.Selective induction of cell death in melanoma cell lines through targeting of Mcl-1 and A1.Formulation of dacarbazine-loaded cubosomes. Part III. Physicochemical characterization.Immunotoxins: a promising treatment modality for metastatic melanoma?Systemic chemotherapy is modulated by platelet-activating factor-receptor agonists.Biomarkers as key contributors in treating malignant melanoma metastases.Systematic review of medical treatment in melanoma: current status and future prospects.mda-7/IL-24: multifunctional cancer-specific apoptosis-inducing cytokineDownregulation of Noxa by RAF/MEK inhibition counteracts cell death response in mutant B-RAF melanoma cells.The therapeutic potential of O6-alkylguanine DNA alkyltransferase inhibitors.The role of estrogen receptor in melanoma.Characterization of highly stable liposomal and immunoliposomal formulations of vincristine and vinblastineCurrent status of primary malignant melanoma of the esophagus: clinical features, pathology, management and prognosis.Combining stereotactic radiosurgery and systemic therapy for brain metastases: a potential role for temozolomideRecent advances and developments in the antitumor effect of the HVJ envelope vector on malignant melanoma: from the bench to clinical application.The oncolytic peptide LTX-315 induces cell death and DAMP release by mitochondria distortion in human melanoma cells.Gold(III) porphyrin 1a prolongs the survival of melanoma-bearing mice and inhibits angiogenesis.Patient derived cell culture and isolation of CD133⁺ putative cancer stem cells from melanoma.Gastrointestinal bleeding as presentation of small bowel metastases of malignant melanoma: Is surgery a good choice?Postoperative DAV-IFN-β therapy does not improve survival rates of stage II and stage III melanoma patients significantly.Stimulation of pulmonary immune responses by the TLR2/6 agonist MALP-2 and effect on melanoma metastasis to the lung.Cisplatin and 4-hexylresorcinol synergise to decrease metastasis and increase survival rate in an oral mucosal melanoma xenograft model: a preliminary study.MMP2 expression is a prognostic marker for primary melanoma patients.
P2860
Q26776032-02D53B8E-BB18-47AB-A8F6-0258F05ECDFDQ30405262-DBB030F4-91DE-493B-81E7-4A750697384CQ33573423-190BE521-307E-4348-A678-FCF8D07DEAB5Q33624296-A9309421-15DA-4FEB-BD3C-A6DC4127C626Q34146431-EF434356-7FE5-4D0B-9AA3-B0C2BF8DFC9AQ34280372-0F4D03DC-FF0F-482A-BAA9-975B8EA7431CQ34986254-D68135EB-D7E2-4600-BBA0-CD7DCF7D276BQ35438088-A1E505B3-C38D-4C07-BE10-D94DA04AA823Q35550888-A281D9F5-4D06-43A9-9CF3-B4BB28202705Q35584299-62555AAC-DEEB-4F1C-83FA-2244BC70D7B6Q35609031-CBF024AC-0CD6-493C-8427-1FF3AD4C7769Q36439920-E0F2AE20-6008-4B90-B2D7-D417563E26E7Q36964700-9C1E4437-0FA2-4334-A954-FC791735399BQ37004756-AE7F05B1-EC0A-4E6E-98FB-B9FCC0BC0ACAQ37279686-305E3218-6207-4B66-9B09-3D10AA12844DQ37952081-D4D55821-54EC-4C31-9B9F-074140C61BF6Q38036217-A3F9B566-8002-496A-8013-AC3B823FD3FCQ38155377-0C3401B6-BEF6-46A3-809D-5F105078635EQ38260167-88C587E0-309D-4742-B97B-E7456696E1A7Q39626962-3A6BF7D6-229C-4C89-AD68-189760871D13Q40128801-A36E5C46-5F47-4B2C-976F-44186BB31E1AQ42934391-0804BFF4-5A87-425F-98C2-C1296778F801Q44248810-06B3E150-7C06-4302-9EFD-23AD2854226DQ48756180-DA8C08C6-D5C9-4184-9CB4-9C1EC8AE538BQ53340945-066B082F-9AF8-46DF-8282-8A13AB7D547EQ54506436-7F7827AE-9767-4F88-B4C1-F07697BD5079
P2860
Systemic chemotherapy in the treatment of malignant melanoma.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
2003年论文
@zh
2003年论文
@zh-cn
name
Systemic chemotherapy in the treatment of malignant melanoma.
@ast
Systemic chemotherapy in the treatment of malignant melanoma.
@en
type
label
Systemic chemotherapy in the treatment of malignant melanoma.
@ast
Systemic chemotherapy in the treatment of malignant melanoma.
@en
prefLabel
Systemic chemotherapy in the treatment of malignant melanoma.
@ast
Systemic chemotherapy in the treatment of malignant melanoma.
@en
P2860
P1476
Systemic chemotherapy in the treatment of malignant melanoma.
@en
P2093
Marko B Lens
Tim G Eisen
P2860
P304
P356
10.1517/14656566.4.12.2205
P407
P577
2003-12-01T00:00:00Z